A bacterial strain, L-1129, identified as Bacillus polymyxa was found to produce a new antibiotic complex, LI-F. The antibiotic complex was isolated from fermentation broth by chromatography on Amberlite XAD-2.HPLCanalysis showedthat the complex was composedof at least ten components. Five components, antibiotics LI-F03, F04, F05, F07, and F08, were isolated from the complex and purified by reversed phase HPLC.Chemical characterization of the components indicated that they were peptides. Although the five antibiotics isolated here behaved as a single entity under all conditions tested for HPLC, their fast atom bombardment mass spectra (FAB-MS) indicated that each antibiotic was a mixture of two homologouscomponents. In this paper, we will describe the production, isolation, physico-chemical and biological properties of the components.
Producing Organism
Antibiotics LI-Fs-producing strain, L-1 129, was isolated from a soil sample collected in Odawara City, Kanagawa Prefecture. The taxonomic study of the strain was carried out according to the Prokaryotes1} and Classification and Identification of Microorganisms2). The taxonomic characteristics of the strain are given below. 3) Gram-stain, prevailing negative. Table 1 . Table 1 indicates that the bacteria should be classified as B. polymyxa. Thus, it was concluded that L-1129 was a strain of B. polymyxa. Production The growth of B. polymyxa L-1 129 on slant culture was used to inoculate two 500-ml Sakaguchi flasks containing 100 ml of sterile medium of Tripticase soy broth (BBL). The flasks were shaken on a reciprocal shaker at 125 strokes per minute for 24 hours at 30°C. The content of the flasks was transferred to a 20-liter volume of stainless steel tank containing 10 liters of fermentation medium composed of corn meal 4.5 %, yeast extracts 0.1 % (NH4)2SO4 0.5% and CaCO3 0.5 %. Fermentation was allowed to proceed at 30°C, at the air flow of 18 liters per minute and with agitation of 400 rpm. Time course of antibiotics production was followed by a cup method using Staphylococcus aureus FDA209P as the test organisms. A peak antibiotic potency of 100 jug/ml was obtained after 22 hours' fermentation.
Morphological Characteristics
Isolation and Purification A flow diagram for the isolation procedure is given in Fig. 1 . Activity against S. aureus FDA 209P was employed to monitor the isolation of antibiotics LI-Fs from the culture broth of B. presence of tyrosine residue, while the other antibiotics showed only end absorption. The individual antibiotics were hydrolyzed with 6 n HC1 at 105°C for 22 hours and the hydrolysates were applied to automatic amino acid analyzer, Hitachi 835 type. The results are shown in Table 2 . All constituent amino acids of antibiotics LI-F03, F04 and F07 were identified, while antibiotic LI-F05 and F08 gave an unidentified amino acid, Ux and U2, respectively, in addition to the identified amino acids. Both the unidentified amino acids seem to be identical with each other as judged by their same retention times. Furthermore, the amino acid analytical results revealed that four amino acids, aspartic acid (Asp), glutamic acid (Glu), alanine (Ala) and threonine (Thr), were common to all the antibiotics and their molar ratios in all the antibiotics were identical. Other constituents such as fatty acid were not found in the hydrolysates. Fig. 6 shows the positive ion FAB-MSof antibiotic LI-F08, giving two intense peaks at m\z 911 and 925. Similarly the FABspectra of other four antibiotics also gave the characteristic homologous peaks, having almost the same intensities, m/z 947 and 961 in LI-F03, m/z 883 and 897 in F04, m/z 897 and 911 in F05, and m/z 931 and 945 in F07, described in Table 2 . As the mass differences between the homologous peaks are fourteen, it was concluded that these peaks were from the protonated molecular ions and each antibiotic isolated was still a mixture of two components. Significant fragment ion peaks were not observed in all spectra.
Biological Activities Antimicrobial Activity The minimal inhibitory concentrations (MICs) of the antibiotics were determined by means of a two-fold serial agar dilution method in Mueller-Hinton media for bacteria, in Sabouraud media for fungi and in yeast morphology media for yeasts. Antibacterial and antifungal spectra of the antibiotics are given in Tables 3 and 4 , respectively.
These antibiotics
were similarly active against Gram-positive bacteria, mycobacteria, and a wide range of fungi and yeasts, whereas no activity was observed on Gram-negative bacteria. mice by a single injection. The results are given in Table 5 .
Discussion
The present work represents a family of closely related new peptide antibiotics. A complex of newpeptide antibiotics, which was composed of more than ten components, was isolated from bacteria reported, they are easily distinguisable from the polymyxin group3) including colistin and circulin, thus they are considered to be new peptide antibiotics. However, antibiotic LI-F04, the most abundant component, might be identical with gatavalin4), because of the identity of their constituent amino acids. The five antibiotics isolated here behaved as a single entity under various HPLCconditions tested. However, it is obvious by the FAB-MSdata that each antibiotic is a mixture of two homologous components. This evidence is also substantiated by the amino acid composition data, which give the calculated molecular weight of more than 1,000 to each antibiotic. Thus, attempts to separate each antibiotic into two components have been performed under various HPLCconditions, but they are unsuccessful till now. Further investigation for the separation and studies on the amino acid sequences of the antibiotics are being continued.
